BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2151370)

  • 1. [Electrocardiographic and echocardiographic changes during antihypertensive therapy].
    Sau F; Seguro C; Pili G; Basciu M; Siddi PP; Tamponi R; Cherchi A
    Cardiologia; 1990 Dec; 35(12):1015-22. PubMed ID: 2151370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronology of regression of hypertensive ventricular hypertrophy during antihypertensive therapy with beta blockers].
    Sau F; Seguro C; Pargentino E
    Cardiologia; 1994 Jul; 39(7):473-9. PubMed ID: 7982244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible regression of left ventricular hypertrophy during antihypertensive treatment with diuretics and/or beta blockers.
    Cherchi A; Sau F; Seguro C
    J Clin Hypertens; 1987 Jun; 3(2):216-25. PubMed ID: 2886561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of the ECG diagnosis of left ventricular hypertrophy in normotensive and moderately hypertensive men when using the echocardiographic assessment of left ventricular mass index as reference.
    Otterstad JE; Froeland G; Wasenius AK; Knutsen KM; Michelsen S; Stugaard M
    J Hum Hypertens; 1991 Apr; 5(2):101-6. PubMed ID: 1830106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Dahlof B;
    Circulation; 2003 Aug; 108(6):684-90. PubMed ID: 12885747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of indenolol on left ventricular mass in patients with essential arterial hypertension].
    Sau F; Seguro C; Lai C; Orani E; Soro A; Onnis E; Cherchi A
    Cardiologia; 1990 Nov; 35(11):925-30. PubMed ID: 2151570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of nifedipine in hypertensive cardiopathy. An echocardiographic and electrocardiographic study].
    Sau F; Seguro C; Lai C; Onnis E; Orani E; Soro A; Leo MR; Cherchi A
    Cardiologia; 1993 Jun; 38(6):369-76. PubMed ID: 8402746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
    Okin PM; Devereux RB; Gerdts E; Snapinn SM; Harris KE; Jern S; Kjeldsen SE; Julius S; Edelman JM; Lindholm LH; Dahlöf B;
    Circulation; 2006 Mar; 113(12):1588-96. PubMed ID: 16534012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
    Dada A; Adebiyi AA; Aje A; Oladapo OO; Falase AO
    Ethn Dis; 2005; 15(4):578-84. PubMed ID: 16259479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study.
    Okin PM; Devereux RB; Liu JE; Oikarinen L; Jern S; Kjeldsen SE; Julius S; Wachtell K; Nieminen MS; Dahlöf B
    J Hum Hypertens; 2004 Jun; 18(6):403-9. PubMed ID: 15057252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is left ventricular systolic dysfunction in hypertensive patients with heart failure normalized by long-term antihypertensive therapy?
    Hamada M; Ohtani T; Suzuki M; Lin M; Kobayashi T; Okayama H; Takezaki M; Hashida K; Abe M; Matsuoka H
    J Cardiol; 1993; 23(2):165-75. PubMed ID: 8176628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular mass and hypertrophy assessment by means of the QRS complex voltage-independent measurements.
    Sosnowski M; Korzeniowska B; Tendera M
    Int J Cardiol; 2006 Jan; 106(3):382-9. PubMed ID: 15996771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO
    Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic administration of the fixed combination slow-release oxprenolol-chlorthalidone on left ventricular hypertrophy in hypertensive patients. Echocardiographic study.
    Bertoni T; Alberti D; Peloso A; Francucci BM; De Ambroggi L
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):148-52. PubMed ID: 2970442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D
    Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regression of left heart hypertrophy in hypertensive patients as a result of antihypertensive therapy].
    Franz IW; Tönnesmann U; Behr U; Ketelhut R
    Z Kardiol; 1989; 78 Suppl 5():43-8. PubMed ID: 2561036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echocardiographic detection of pressure-overload left ventricular hypertrophy: effect of criteria and patient population.
    Devereux RB; Casale PN; Hammond IW; Savage DD; Alderman MH; Campo E; Alonso DR; Laragh JH
    J Clin Hypertens; 1987 Mar; 3(1):66-78. PubMed ID: 2952768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.